MGMT and glioblastoma: Overall, it can be concluded, that a partial correlation of an effective MGMT silencing via epigenetic alterations is present in a portion of patients with GBM, while in others a “mosaic-like” pattern, such as unmethylated MGMT promoter and low protein expression or methylated MGMT promoter and present MGMT protein expression, exist.